Biomarker and cognitive associates of resistance to neocortical tau pathology in a pooled cohort
Year: 2025
Type: article
Abstract: Background Prior evidence suggests that neocortical tau in those with higher β‐amyloid (Aβ) may be the main driver of Alzheimer's disease (AD)‐related neurodegeneration leading to insidious cognitive decline and ultimately a diagnosis of AD dementia. Resistance to the ‘spread’ of neocortical tau pathology from localized medial temporal (MTL) regions can be defined as individuals having lower neocortical tau than expected given their individual characteristics, such as demographics and Aβ burden. We examined associations between resistance to neocortical tau pathology and various markers of AD pathology, cognitive performance, and brain reserve. Method We calculated tau resistance using our published inverse learning method (Figure 1B), which estimates the deviation away from a model trained on an expectation sample (278 Aβ‐PET+ older adults with high neocortical tau‐PET (PVC_SUVR composite :inferior temporal/inferior parietal/fusiform/middle temporal) burden based on Gaussian Mixture Modeling;Figure 2A). We ran a series of linear regression models on the remaining 1,374 older adults pooled from the Harvard Aging Brain Study (HABS), ADNI, and A4/LEARN (Demographics in Figure 1A). We examined associations between tau resistance and 1) MTL tau‐PET (PVC_SUVR composite ; entorhinal/amygdala/parahippocampal), 2) measures of brain reserve (hippocampal volume and entorhinal cortical thickness), 3) neocortical Aβ‐PET burden (Centiloids), 4) an interaction between MTL tau and Aβ‐PET, and 5) cognitive performance (PACC). All models adjusted for age, sex, education, cohort, and APOE ε4. Results Lower MTL tau, lower Aβ, and younger age were significantly associated with higher neocortical tau resistance (β MTL =‐0.22(0.06), p < 0.001, Figure 2B; β Aβ =‐0.13(0.03), p <0.001Figure 2C;β Age =‐0.62(0.02), p < 0.001). Higher PACC, greater hippocampal volume and thicker entorhinal cortices were associated with lower resistance (β PACC =‐0.29(0.02), p < 0.001, Figure 2D;β HV =‐0.10(0.03), p < 0.001, β EC_thickness =‐0.14(0.03), p < 0.001). Greater Aβ and MTL tau burden interacted to influence lower resistance (Figure 3). In a sample limited to Aβ+ ( N = 537), we found only lower PACC and younger age significantly associated with tau resistance. Conclusion These findings suggest that baseline levels of MTL tau and age play a role in resisting the advancement of tauopathy into neocortical brain regions, and might be mediated by Aβ in early disease stages. The counter‐intuitive association with cognition and brain reserve measures implies that tau resistance is most likely represented by those with greater cognitive impairment and lower reserve, as neocortical tau burden is much lower in clinically‐normal older adults.
Source: Alzheimer s & Dementia
Authors: Colin Birkenbihl, Hannah M Klinger, Michael J. Properzi, Madison Cuppels, Jane A Brown, Gillian T Coughlan, Mabel Seto, Annie Li, Jasmeer P. Chhatwal, Bernard J Hanseeuw, Michelle E. Farrell, Heidi I.L. Jacobs, Maria Carrigan, Oliver Langford, Julie C Price, Aaron P. Schultz, Dorene M. Rentz, Rebecca E. Amariglio, Keith A. Johnson, Reisa A. Sperling, Michael C. Donohue, Timothy J. Hohman, Rachel F. Buckley
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,200
OpenAlex ID: W7117305169
FWCI:
Cites:
Cited by:
Related to: